{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"description":"Disease free survival refers to patients with no evidence of disease after transplant, at the Day 100 time point.","groups":[{"description":"Patients receiving Fludarabine, Busulfan, cyclophosphamide and post-transplant cyclophosphamide for a haploidentical donor transplant","id":"OG000","title":"Haploidentical Transplant"}],"paramType":"NUMBER","populationDescription":"17 patients were alive at Day 100 and therefore were eligible to be evaluated for disease free survival at D100","reportingStatus":"POSTED","timeFrame":"Day 100","title":"Disease Free Survival at Day 100","type":"SECONDARY","unitOfMeasure":"participants"}